Skip to main content

CTT Pharmaceutical Holdings, Inc.

corporate_fare Company Profile

CTT Pharmaceutical Holdings, Inc.

CTTH·OTC·Life Sciences·CIK 0001035422

CTT Pharmaceutical Holdings, Inc. is a development stage company focused on drug delivery systems technology within the pharmaceutical industry. The company specializes in fast dissolving drug delivery systems, specifically an oral delivery system of medication contained on a disposable film. CTT Pharmaceutical Holdings, Inc. was incorporated on November 6, 1996, as Winchester Mining Corp. The company underwent several name changes, becoming PNW Capital, Inc. on May 16, 2000, and then Industrial Minerals, Inc. in 2002 after acquiring Industrial Minerals Incorporated. Effective July 26, 2011, the company adopted the name Mindesta Inc. and consolidated its stock on a 20:1 basis. Operations ceased in 2013 due to financial difficulties. On September 9, 2014, the company entered into a Share Exchange Agreement with CTT Pharmaceuticals, Inc., f/k/a Fenwafe Inc., a Canadian entity organized in March 2007. Through this agreement, the company acquired all issued and outstanding shares of CTT Pharma common stock by issuing 149,183,285 shares of its own common stock. Of these, 8,444,337 shares were issued to Capital Financial to satisfy an obligation of CTT Pharma. The 149,183,285 restricted common shares issued at closing represented approximately 80% of the then issued and outstanding shares of the company's common stock. Effective July 20, 2015, the company changed its name to CTT Pharmaceutical Holdings, Inc. CTT Pharma is now a wholly owned subsidiary and the company's exclusive focus, with all previous business operations abandoned.

CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for CTTH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 10/10, with 5 rated 8 or above. Recent SEC coverage for CTTH spans 10-Q, 8-K, S-1/A.

Recent high-impact activity:

  • CTT Pharma Q3 2026: Cash Down to $12,625, Loss Widens to $127,064, Going Concern Stands
  • Auditor Resigns at CTT Pharma Amid Going-Concern Warning
  • CTT Pharma Q2 10-Q: Going Concern, $31 Cash, Two Material Weaknesses
  • CTT Pharma Amends S-1 to Detail $1M ELOC Use, Reports Nicotine Strip Patent Approval
  • CTT Pharma Amends S-1 to Register 6.25M Shares for Resale Under $10M Equity Line, Details Use of Proceeds

Financial Snapshot

Fiscal year ended December 31, 2014
Net Income
-$672.16K
Op. Cash Flow
-$72.25K
Operating Income
-$672.16K
Cash & Equivalents
$81.18K
Debt / Equity
0.00×
Shares Outstanding
19.51M sh
Source: 10-K · filed 2015-10-08 · accession 0001553350-15-001055

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 19,151 shares in CTTH as of the October 30, 2026 settlement, a 5.5% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 8.5% of CTTH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)19,151 shares as of October 30, 2026
Change vs prior period▲ 5.5%
Days to cover1.00 at avg daily volume of 19,600
Daily short volume (FINRA facilities)8.5% of 15,000 shares on November 20, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for CTTH, detected from its recent SEC filings · based on capital-structure filings through 2026-07-13.

1 shelf registration

Fifth Amendment to S-1 Filed · No New Material Terms

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$0.054 +10.20% today
52-week range · as of 2026-11-18 $0.035 – $0.10
Market cap
$3.32M
Volume
15K (0.4× avg)
3-mo avg 34.5K
Live data · 2026-11-22 03:36 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CTTH - Latest Insights

CTTH
Nov 18, 2026, 11:42 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.049
Real-time Price: $0.054 info
Change: +$0.0050 (+10%) info
Market Cap: $3.322M info
CTTH
Oct 07, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0566
Real-time Price: $0.054 info
Change: -$0.0026 (-5%) info
Market Cap: $3.322M info
CTTH
Sep 17, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0479
Real-time Price: $0.054 info
Change: +$0.0061 (+13%) info
Market Cap: $3.322M info
CTTH
Jun 29, 2026, 10:33 AM EDT
Filing Type: S-1/A
Importance Score:
7
Price at Filing: $0.075
Real-time Price: $0.054 info
Change: -$0.021 (-28%) info
Market Cap: $3.322M info
CTTH
May 29, 2026, 2:22 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.080
Real-time Price: $0.054 info
Change: -$0.026 (-33%) info
Market Cap: $3.322M info
CTTH
Apr 14, 2026, 6:23 PM EDT
Filing Type: S-1/A
Importance Score:
10
Price at Filing: $0.0697
Real-time Price: $0.054 info
Change: -$0.0157 (-23%) info
Market Cap: $3.322M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets